HHG & Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-26,302
Closed -$1.76M 136
2015
Q3
$1.76M Sell
26,302
-8,164
-24% -$601K 0.53% 61
2015
Q2
$2.55M Sell
34,466
-45
-0.1% -$3.44K 0.74% 40
2015
Q1
$2.69M Buy
34,511
+734
+2% +$55.6K 0.71% 39
2014
Q4
$2.44M Sell
33,777
-1,531
-4% -$106K 0.58% 45
2014
Q3
$2.19M Sell
35,308
-918
-3% -$58.4K 0.71% 39
2014
Q2
$2.31M Buy
36,226
+1,941
+6% +$118K 0.75% 45
2014
Q1
$2.11M Buy
34,285
+1,265
+4% +$73.7K 0.72% 47
2013
Q4
$1.9M Buy
33,020
+1,860
+6% +$105K 0.7% 43
2013
Q3
$1.66M Sell
31,160
-190
-0.6% -$10.2K 0.67% 46
2013
Q2
$1.61M Buy
+31,350
New +$1.55M 0.65% 46

Other funds holding MDT

HHG & Company's MDT Position: Q4 2015 in Review

HHG & Company sold out of Medtronic (MDT) in Q4 2015, closing a stake of 26,302 shares — an estimated $1.76M sold.

HHG & Company first reported a position in MDT in Q2 2013 and held it in 10 quarters. The position peaked at $2.69M in Q1 2015. 1,252 funds tracked by Wall St. Rank hold MDT as of Q4 2015.

  • HHG & Company reported no remaining Medtronic position as of Q4 2015 after selling out during the quarter.
  • HHG & Company sold 26,302 Medtronic shares in Q4 2015, an estimated $1.76M.
  • HHG & Company first reported a position in Medtronic in Q2 2013 and held it in 10 quarters.
  • HHG & Company's Medtronic position peaked at $2.69M in Q1 2015.
  • 1,252 funds tracked by Wall St. Rank held Medtronic as of Q4 2015.

Based on HHG & Company's 13F filing for Q4 2015, filed 19 Jan 2016.